Pre-treating human NK cells with dasatinib increases cytotoxicity against resistant Daudi but not sensitive K562 or Jurkat cells - An example for differential immunomodulation

被引：0
|
作者：
Hassold, N. [1 ]
Seystahl, K. [1 ]
Dix, C. [1 ]
Wischhusen, J. [1 ]
Einsele, H. [1 ]
Seggewiss, R. [1 ]
机构：
[1] Univ Wurzburg, Wurzburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S267 / S268
页数：2
相关论文
共 30 条
  • [1] Proteomic analysis of human NK-92 cells after NK cell-mediated cytotoxicity against K562 cells
    Liu, Xi-Cheng
    Liang, Heng
    Tian, Zhen
    Ruan, Yu-Song
    Zhang, Lin
    Chen, Yang
    BIOCHEMISTRY-MOSCOW, 2007, 72 (07) : 716 - 727
  • [2] Proteomic analysis of human NK-92 cells after NK cell-mediated cytotoxicity against K562 cells
    Xi-Cheng Liu
    Heng Liang
    Zhen Tian
    Yu-Song Ruan
    Lin Zhang
    Yang Chen
    Biochemistry (Moscow), 2007, 72 : 716 - 727
  • [3] The potential markers of NK-92 associated to cytotoxicity against K562 cells
    Song, Xue
    Xu, Chongfeng
    Wu, Xueling
    Zhao, Xiang
    Fan, Jinping
    Meng, Shufang
    BIOLOGICALS, 2020, 68 : 46 - 53
  • [4] Novel Palladium Complex: Cytotoxicity against Cisplatin-resistant K562 Cells
    Jahanian-Najafabadi, Ali
    Mirian, Mina
    Rohani, Fatemeh
    Karami, Kazem
    Kharat, Mahboubeh Hosseini
    Sadeghi-Aliabadi, Hojjat
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (03): : 1323 - 1331
  • [5] Cellular uptake, cytotoxicity, and transport kinetics of anthracyclines in human sensitive and multidrug-resistant K562 cells
    Praet, M
    Stryckmans, P
    Ruysschaert, JM
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (10) : 1341 - 1348
  • [6] Limocitrin increases cytotoxicity of KHYG-1 cells against K562 cells by modulating MAPK pathway
    Hsieh, Ming-Ju
    Lin, Jen-Tsun
    Chuang, Yi-Ching
    Lin, Chia-Chieh
    Lo, Yu-Sheng
    Ho, Hsin-Yu
    Chen, Mu-Kuan
    ENVIRONMENTAL TOXICOLOGY, 2023, 38 (12) : 2939 - 2951
  • [7] INHIBITION OF HUMAN NK CELL CYTO-TOXICITY AGAINST K562 CELLS WITH GLYCOPEPTIDES FROM K562 PLASMA-MEMBRANES
    DECKER, JM
    HINSON, A
    ADES, EW
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1984, 15 (03) : 137 - 143
  • [8] IMATINIB INCREASES CYTOTOXICITY OF MELPHALAN AND DECREASES PROLONGATION OF G2-M PHASE IN HUMAN K562 CELLS
    Giallongo, C.
    Tibullo, D.
    La Cava, P.
    Parrinello, N.
    Romano, A.
    Cavalli, M.
    Conticello, C.
    Palumbo, G. A.
    Di Raimondo, F.
    HAEMATOLOGICA, 2008, 93 : S66 - S66
  • [9] HETEROGENEOUS BINDING AND KILLING BEHAVIOR OF HUMAN GAMMA DELTA-TCR+ LYMPHOKINE-ACTIVATED KILLER-CELLS AGAINST K562 AND DAUDI CELLS
    VOLLENWEIDER, I
    VRBKA, E
    FIERZ, W
    GROSCURTH, P
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (05) : 331 - 336
  • [10] SUPPRESSION OF STAT5A INCREASES CHEMOTHERAPEUTIC SENSITIVITY IN IMATINIB-RESISTANT AND IMATINIB-SENSITIVE K562 CELLS
    Baran, Y.
    Kosova, B.
    Tezcanli, B.
    Ekiz, H.
    Cakir, Z.
    Selvi, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 357 - 357
123